Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced...
Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated...
STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused...
WOBURN, Mass., Jan. 22, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, has published...
Live webcast on Wednesday, January 29th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics...
Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, patient population...
REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical...
New intranasal formulation with significantly improved stability was well-tolerated and led to local activation of innate immune pathways in adults...
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters...
TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare technologies Inc. (NASDAQ: MRM) (“MEDIROM”), a health technology and holistic healthcare...
Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industriesNEW YORK, Jan. 21,...
COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on...
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S....
DELRAY BEACH, Fla., Jan. 17, 2025 /PRNewswire/ -- The global healthcare supply chain management market, valued at US$ 3.51 billion in 2023,...
Strategic hire underscores Emmes Group's growth and commitment to biopharma market ROCKVILLE, Md., Jan. 16, 2025 /PRNewswire/ -- Emmes Group®,...
Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to...
ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) --...
MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...